MedDataX Logo

Pneumological Acute Coronary Syndrom (ACS) Phenotyping Aachen

NCT ID: NCT02587481

Last Updated: 2017-11-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-11-30

Study Completion Date

2017-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this open, monocentric, observational study acute coronary syndrom (ACS) patients will be characterized by pneumological examination concerning a concomitant chronic obstructive pulmonary disease (COPD). Often COPD coexists with ACS; therefore ACS patients benefit either from prevention or potential therapy of chronic hypoxia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In this study patients with either non ST-segment-elevation myocardial infarction (NSTEMI) or ST-segment-elevation myocardial infarction (STEMI) will be included. After amnesis patients will undergo blood withdrawal, blood-gas analysis and examinations concerning pulmonary function (Bodyplethysmography). In addition to routine blood withdrawal for differential blood count, 9 ml blood sample is takenfor molecular analysis of relevant prognostic chronic obstructive pulmonary disease (COPD)-blood based biomarkers, an for establishing a library of biomaterial in form of a biobank.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Coronary Syndrom Chronic Obstructive Pulmonary Syndrom

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Acute coronary syndrom Chronic obstructive pulmonary disease Myocardial infarction Blood based biomarkers

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Written declaration of consent
* Patients with acute myocardial infarct which can be either non ST-segment-elevation myocardial infarct (NSTEMI) or ST-segment-elevation myocardial infarct (STEMI), in both cases exaggeration of cardiac ischaemic markers

Exclusion Criteria

* Patients not fulfilling the incluson criterias or:
* Pregnant or breastfeeding women
* Participation in other studies
* Persons in depency from the sponsor or working with the sponsor
* Persons without mental ability or capacity to understand and follow the instructions of the investigator
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

RWTH Aachen University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Michael Dreher, Univ.-Prof. Dr. med.

Role: PRINCIPAL_INVESTIGATOR

RWTH Aachen University Hospital MK1

VIncent Brandenburg, apl. Prof. Dr. med

Role: PRINCIPAL_INVESTIGATOR

RWTH Aachen University Hospital MK1

Christian Cornelissen, Dr. med

Role: PRINCIPAL_INVESTIGATOR

RWTH Aachen University Hospital MK1

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Amrei Pelzer

Aachen, North Rhine-Westphalia, Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

15-057

Identifier Type: -

Identifier Source: org_study_id